葛兰素史克(GSK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GSK 葛兰素史克

盘后交易 01-20 18:56:01 EST

47.65

-0.57

-1.18%

盘后47.74

+0.09+0.19%

18:52 EST

最高48.35	最低47.62	成交量820.12万
今开48.05	昨收48.22	日振幅1.50%
总市值971.08亿	流通市值927.69亿	总股本20.38亿
成交额3.93亿	换手率0.42%	流通股本19.47亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GSK","market":"US","secType":"STK","nameCN":"葛兰素史克","latestPrice":47.65,"timestamp":1768942800000,"preClose":48.22,"halted":0,"volume":8201186,"hourTrading":{"tag":"盘后","latestPrice":47.74,"preClose":47.65,"latestTime":"18:52 EST","volume":931266,"amount":44368840.584684,"timestamp":1768953122348,"change":0.09,"changeRate":0.001889,"amplitude":0.004397},"delay":0,"changeRate":-0.011820821236001665,"floatShares":1946891708,"shares":2037944753,"eps":3.572046,"marketStatus":"盘后交易","change":-0.57,"latestTime":"01-20 18:56:01 EST","open":48.05,"high":48.345,"low":47.62,"amount":392981724.35662,"amplitude":0.015035,"askPrice":47.74,"askSize":300,"bidPrice":47.6,"bidSize":1,"shortable":3,"etf":0,"ttmEps":3.572046,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1768957200000},"marketStatusCode":4,"adr":1,"adrRate":2,"listingDate":977893200000,"exchange":"NYSE","adjPreClose":48.22,"dividendRate":0.035974,"preHourTrading":{"tag":"盘前","latestPrice":48.07,"preClose":48.22,"latestTime":"09:29 EST","volume":74052,"amount":3568084.690104,"timestamp":1768919399529,"change":-0.15,"changeRate":-0.003111,"amplitude":0.010784},"postHourTrading":{"tag":"盘后","latestPrice":47.74,"preClose":47.65,"latestTime":"18:52 EST","volume":931266,"amount":44368840.584684,"timestamp":1768953122348,"change":0.09,"changeRate":0.001889,"amplitude":0.004397},"volumeRatio":1.700997,"impliedVol":0.301,"impliedVolPercentile":0.6813},"requestUrl":"/m/hq/s/GSK","defaultTab":"news","newsList":[{"id":"2604837114","title":"英国葛兰素史克（GSK）股价上涨63.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604837114","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604837114?lang=zh_cn&edition=full","pubTime":"2026-01-20 22:40","pubTimestamp":1768920001,"startTime":"0","endTime":"0","summary":"每经AI快讯，1月20日，英国葛兰素史克（GSK）将以22亿美元收购RAPT治疗公司后，该公司股价上涨63.7%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601203625019852.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601203625019852.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","GSK","LU1829250122.USD","BK4532","GSK.UK","BK4007","BK4585"],"gpt_icon":0},{"id":"2604113507","title":"GSK 达成一笔 22 亿美元的收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2604113507","media":"丁香园 Insight 数据库","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604113507?lang=zh_cn&edition=full","pubTime":"2026-01-20 16:23","pubTimestamp":1768897383,"startTime":"0","endTime":"0","summary":"1 月 20 日，GSK 宣布已达成最终协议，收购 RAPT Therapeutics。截图来源：企业官网根据协议条款，GSK 将在交易完成时向 RAPT Therapeutics 股东支付每股 58.00 美元，预计总股权价值为22 亿美元。扣除收购的现金后，GSK 预计的前期投资为 19 亿美元。此次交易使GSK 获得 Ozureprubart 项目的全球权益，但不包括中国大陆、澳门、台湾和香港地区。GSK 还将负责向 RAPT 的合作伙伴济民可信支付Ozureprubart项目基于成功研发的里程碑付款和特许权使用费。该交易预计将于 2026 年第一季度完成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120171645a4405fbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120171645a4405fbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4532","BK4585","GSK","RAPT","LU1829250122.USD","GSK.UK","BK4007","BK4139"],"gpt_icon":0},{"id":"2604167450","title":"葛兰素史克将收购生物制药公司RAPT","url":"https://stock-news.laohu8.com/highlight/detail?id=2604167450","media":"南方财经网","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604167450?lang=zh_cn&edition=full","pubTime":"2026-01-20 15:36","pubTimestamp":1768894560,"startTime":"0","endTime":"0","summary":"南方财经1月20日电，据界面新闻，葛兰素史克1月20日宣布，已同RAPTTherapeutics达成最终收购协议。RAPT是一家位于美国加州的临床阶段生物制药公司，致力于为患有炎症和免疫疾病的患者开发新型疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601203624628683.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4532","GSK","GSK.UK","BK4007","BK4588","RAPT","BK4139","BK4585","LU1829250122.USD"],"gpt_icon":0},{"id":"1117194686","title":"葛兰素史克与RAPT Therapeutics达成收购协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1117194686","media":"老虎资讯综合","labels":[],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117194686?lang=zh_cn&edition=full","pubTime":"2026-01-20 15:11","pubTimestamp":1768893065,"startTime":"0","endTime":"0","summary":"1月20日，RAPT Therapeutics美股夜盘飙升近20%！葛兰素史克(GSK.N)：将以每股58美元收购Rapt，股权价值为22亿美元。预计前期投入资金为19亿美元。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"葛兰素史克与RAPT Therapeutics达成收购协议","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPT","GSK"],"gpt_icon":0},{"id":"2604574162","title":"葛兰素史克(GSK.US)：将以每股58美元收购Rapt，股权价值为22亿美元。预计前期投入资金为19亿美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2604574162","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604574162?lang=zh_cn&edition=full","pubTime":"2026-01-20 15:07","pubTimestamp":1768892854,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["GSK.UK","BK4585","BK4532","BK4588","GSK","BK4007","LU1829250122.USD"],"gpt_icon":0},{"id":"2603603977","title":"跨国巨头艾伯维锚定本土创新，全球资源如何加速落地中国？","url":"https://stock-news.laohu8.com/highlight/detail?id=2603603977","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603603977?lang=zh_cn&edition=full","pubTime":"2026-01-15 17:33","pubTimestamp":1768469598,"startTime":"0","endTime":"0","summary":"三生制药将一款处于临床阶段的双特异性抗体药物以60.5亿美元的价格授权给辉瑞；恒瑞医药与葛兰素史克（GSK）达成潜在价值125亿美元的交易；信达生物与武田制药就三款产品达成114亿美元的交易……当下，中国生物医药行业的交易纪录正被本土创新力量持续刷新。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601153620504655.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601153620504655.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4080","ADC","BK4532","BK4585","GSK","LU1829250122.USD","BK4588","BK4231","BK4007","GSK.UK"],"gpt_icon":0},{"id":"2602006340","title":"千亿美元“专利悬崖”逼近！美股制药巨头瞄准收购新药，中小盘生物科技股迎来“超级溢价”投资盛宴？","url":"https://stock-news.laohu8.com/highlight/detail?id=2602006340","media":"智通财经","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602006340?lang=zh_cn&edition=full","pubTime":"2026-01-09 16:00","pubTimestamp":1767945631,"startTime":"0","endTime":"0","summary":"而多种因素共同促成了生物科技并购的爆发式增长。一些全球最畅销的药物正面临在关键地区失去专利保护的风险，这被业内称为“专利悬崖”。据计算，到2032年，畅销品牌专利保护期的丧失将造成至少1739亿美元的年销售额损失。生物科技板块近几年经历繁荣、衰退，然后又是繁荣新冠疫情期间，生物科技行业迅速成为投资者的热门之选。Loren表示，一系列利好数据也推高了生物科技股的估值。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390856.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"美股制药巨头瞄准收购新药，中小盘生物科技股迎来“超级溢价”投资盛宴？","news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LLY","NVS","GSK","AZN","BMY","PFE","MRK","NVO"],"gpt_icon":1},{"id":"2601338351","title":"GSK(GSK.US)突破性乙肝疗法达3期试验主要终点 上市申请递交在即","url":"https://stock-news.laohu8.com/highlight/detail?id=2601338351","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601338351?lang=zh_cn&edition=full","pubTime":"2026-01-08 08:44","pubTimestamp":1767833062,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，GSK今日宣布，其与Ionis Pharmaceuticals合作开发的在研反义寡核苷酸疗法bepirovirsen，在用于治疗慢性乙型肝炎的两项关键性3期临床试验B-Well 1和B-Well 2中取得积极结果。两项试验均达到主要终点。GSK计划于2026年第一季度启动全球监管申报。慢性乙型肝炎是全球范围内的一项重大健康挑战，影响着超过2.5亿人，并且已成为导致肝癌的主要原因之一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390157.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"GSK(GSK.US)突破性乙肝疗法达3期试验主要终点 上市申请递交在即","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GSK.UK","BK4532","BK4585","LU1829250122.USD","GSK","BK4588","BK4007"],"gpt_icon":0},{"id":"2601954658","title":"葛兰素史克盘前涨超2%在日本获得支气管哮喘治疗的监管批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2601954658","media":"动脉网","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601954658?lang=zh_cn&edition=full","pubTime":"2026-01-06 17:28","pubTimestamp":1767691680,"startTime":"0","endTime":"0","summary":"葛兰素史克1月6日盘前股价涨超2%，报50.08美元。消息面上，其用于治疗支气管哮喘及伴鼻息肉慢性鼻窦炎的药物Exdensur（通用名：depemokimab）在日本获得监管批准。该药物此前已在美国和英国获批上市，目前正在包括中国在内的其他多个市场接受监管审查。此次日本获批，意味着葛兰素史克在拓展Exdensur市场方面取得新进展，不仅为日本当地支气管哮喘及伴鼻息肉慢性鼻窦炎患者带来新治疗选择，也进一步巩固了葛兰素史克在全球制药领域的地位，后续该药物在其他市场的审查结果也备受关注。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106173839a6f9cef6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106173839a6f9cef6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GSK","BK4588","GSK.UK","LU1829250122.USD","BK4532","BK4585"],"gpt_icon":0},{"id":"2595735795","title":"2025医药健康回眸：在进阶中创新，于规范中前行","url":"https://stock-news.laohu8.com/highlight/detail?id=2595735795","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595735795?lang=zh_cn&edition=full","pubTime":"2025-12-30 18:06","pubTimestamp":1767089169,"startTime":"0","endTime":"0","summary":"2025年，是中国生物医药行业在挑战中坚守初心、于变局中锚定方向的一年。这一年，行业融资市场的寒意未完全消退。数据显示，2025年上半年，国内创新药企业完成134起融资，数量创近十年同期新低；一级市场公开交易笔数与总额，亦呈逐月下降趋势。所幸，寒意挡不住创新的光芒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512303605802113.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512303605802113.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK1574","BK4007","06978","BK4588","09939","BK4532","GSK.UK","GSK","BK4585","LU1829250122.USD","BK1515"],"gpt_icon":0},{"id":"2595760438","title":"AlphaValue：将葛兰素史克目标价上调至2186便士","url":"https://stock-news.laohu8.com/highlight/detail?id=2595760438","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595760438?lang=zh_cn&edition=full","pubTime":"2025-12-30 16:44","pubTimestamp":1767084257,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["GSK.UK","BK4585","BK4532","BK4588","GSK","BK4007","LU1829250122.USD"],"gpt_icon":0},{"id":"2593469996","title":"2025生物制药5大失败临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2593469996","media":"医药魔方","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593469996?lang=zh_cn&edition=full","pubTime":"2025-12-23 10:10","pubTimestamp":1766455833,"startTime":"0","endTime":"0","summary":"Biospace近日总结了生物制药领域在2025年五项代价高昂的临床失败，并分析了其引发的连锁反应。Alector与GSK于2021年7月达成合作，GSK投入预付款7亿美元，并承诺最高15亿美元的里程碑付款，以合作研发两款神经领域药物。双方2021年协议中的第二款药物nivisnebart目前处于II期研发阶段，用于治疗早期阿尔茨海默病。▌诺和诺德GLP-1药物阿尔茨海默适应症临床试验失利在神经科学领域折戟的还有诺和诺德。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223102629a46cc8bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223102629a46cc8bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PFE","IE00BLSP4452.SGD","LU1093756168.USD","LU0154236417.USD","LU1829250122.USD","LU0122379950.USD","LU0306807586.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU0225771236.USD","LU0234572021.USD","SG9999011175.SGD","BK4568","GSK","BK4139","BK4585","BK4213","LU1894683264.USD","SG9999003800.SGD","LU1057294990.SGD","SG9999002224.SGD","IE00B19Z3B42.SGD","NVO","BK4007","ALEC","BK4534","BK4592","IE00BBT3K403.USD","LU0985481810.HKD","LU1066051498.USD","SG9999013999.USD","BK4599","GSK.UK","LU0456855351.SGD","LU0289739699.SGD","IE00BLSP4239.USD","BK4588","LU0306806265.USD","LU0868494617.USD","LU0321505868.SGD","IE000M9KFDE8.USD","LU0058720904.USD","BK4532","LU0225284248.USD","LU0321505439.SGD","LU1883839398.USD","LU1093756325.SGD","LU1894683348.USD","IE0002270589.USD","SG9999002232.USD","BK4581","SGXZ57979304.SGD","SG9999001176.USD","LU1023059063.AUD","BMY","SG9999001176.SGD","LU1066053197.SGD","IE00B19Z3581.USD","BK4533","LU0170899867.USD","BK4550"],"gpt_icon":1},{"id":"2593546606","title":"同日多家药企新药在华获批上市，自研罕见病创新药引人注目","url":"https://stock-news.laohu8.com/highlight/detail?id=2593546606","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593546606?lang=zh_cn&edition=full","pubTime":"2025-12-23 09:44","pubTimestamp":1766454240,"startTime":"0","endTime":"0","summary":"2025年药企研发热情和创新活力强劲，12月15日至21日，CDE批准超20款1类创新药临床试验申请，12月22日多家药企新药在华获批上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223095030a6c3a87e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223095030a6c3a87e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4532","BK4599","LU1093756168.USD","IE00BZ1G4Q59.USD","LU1093756325.SGD","NVO","LU0154236417.USD","GSK","BK4585","BK4588","MRK","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"2592192144","title":"特朗普标榜“大胜”：九大药企达成降价协议换取三年关税豁免","url":"https://stock-news.laohu8.com/highlight/detail?id=2592192144","media":"华尔街见闻","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592192144?lang=zh_cn&edition=full","pubTime":"2025-12-20 08:48","pubTimestamp":1766191729,"startTime":"0","endTime":"0","summary":"默沙东、诺华、葛兰素史克等九家药企签署协议后，特朗普称，今夏被政府盯上的17家药企中已有14家同意“大幅”降价。美商务部长暗示，剩余三家将在年末假期后宣布类似的协议。","market":"sg","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3761750","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3761750","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"特朗普标榜“大胜”：九大药企达成降价协议换取三年关税豁免","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRK","GSK","NVS"],"gpt_icon":1},{"id":"2592139231","title":"默沙东(MRK.US)、施贵宝(BMY.US)等多家药企同意下调美国药价 以换取特朗普政府关税豁免和政策支持","url":"https://stock-news.laohu8.com/highlight/detail?id=2592139231","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592139231?lang=zh_cn&edition=full","pubTime":"2025-12-20 07:00","pubTimestamp":1766185200,"startTime":"0","endTime":"0","summary":"美国总统特朗普推动将美国药价与海外低价市场挂钩之际，多家美国及欧洲大型制药企业近日与白宫达成协议，同意自愿下调在美销售的药品价格，以换取关税豁免和政策支持。在此次协议中，最受市场关注的是施贵宝的让利承诺。特朗普在周五的公开活动上表示，今年7月他致信要求降价的17家大型制药企业中，已有14家同意大幅下调药价。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2acbaf8fbf691a451fa9ea170ee88816","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384042.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1061106388.HKD","LU1571399168.USD","LU1201861249.SGD","SG9999001440.SGD","LU0114720955.EUR","LU0266013472.USD","IE00BLSP4452.SGD","GILD","LU1323610961.USD","BK4007","LU1116320737.USD","LU0006306889.USD","LU1066051225.USD","LU0882574055.USD","SG9999002232.USD","IE00B2B36J28.USD","LU0096364046.USD","LU2125154778.USD","IE00BSNM7G36.USD","LU1929549753.HKD","IE00BLSP4239.USD","LU1093756168.USD","LU1934455277.USD","LU1032466523.USD","LU0211331839.USD","LU0234572021.USD","LU1934455194.USD","LU1670711123.USD","LU1868836591.USD","LU0861579265.USD","LU1162221912.USD","BK4516","IE00B4R5TH58.HKD","LU0208291251.USD","SG9999014559.SGD","LU2112291526.USD","SNY","LU0985320562.USD","BK4559","IE00BBT3K403.USD","LU0306806265.USD","LU2089984988.USD","LU0306807586.USD","LU0203347892.USD","LU2468319806.SGD","LU2361045086.USD","BK4533","LU0106261372.USD","LU0058720904.USD","LU1430594728.SGD","LU1037948541.HKD","LU2361044865.SGD","LU1074936037.SGD","LU0238689110.USD","BK4532","LU0070302665.USD","LU2242652126.USD","LU2125154935.USD","LU2360032135.SGD","IE00BJT1NW94.SGD","LU1934455863.HKD","LU0225284248.USD","AMGN","IE0002141913.USD","LU1035773651.USD","BK4550","LU1868836757.USD","LU0203345920.USD","LU0265550359.USD","REGN","LU1718418525.SGD","GSK","LU2133065610.SGD","LU1941712348.USD","LU1066051811.HKD","LU1093756325.SGD","LU0098860793.USD","LU1974910355.USD","BK4585","LU1989771016.USD","NVS","BMY","LU2324357040.USD","LU1023059063.AUD","IE000M9KFDE8.USD","SG9999013999.USD","04332","IE00BFXG1179.USD","LU0321505439.SGD","SG9999001176.USD","AZN","LU1670710661.SGD","LU0237698245.USD","LU1585245621.USD","IE0009355771.USD","LU0225771236.USD","LU2106854487.HKD","SG9999001176.SGD","LU2242646821.SGD","LU0267386448.USD","LU1868836914.USD","LU0130102774.USD","LU2023250843.SGD","LU1989772923.USD","LU2023250504.SGD","BK4581","LU1057294990.SGD","LU0265550946.USD","LU1069347547.HKD","LU0320765646.SGD","LU1989772840.SGD","LU2361044949.HKD","LU1670710588.SGD","LU1670711040.USD","SG9999014542.SGD","IE00BJJMRZ35.SGD","SG9999014575.USD","SG9999002224.SGD","SG9999015341.SGD","LU1917777945.USD","IE00BFTCPJ56.SGD","LU0965509283.SGD","IE00BN8TJ469.HKD","LU1983299246.USD","LU1699723380.USD","MRK","IE00B1BXHZ80.USD","LU0321505868.SGD","LU1037948897.HKD","LU1116320901.HKD","LU1261432733.SGD","LU0980610538.SGD","LU1868837300.USD","LU0289739699.SGD","JNJ","LU0122379950.USD","LU1066051498.USD","SG9999014567.USD","LU0456855351.SGD","LU0868494617.USD","LU2461242641.AUD","LU0648001328.SGD","LU0965509010.AUD","LU0985481810.HKD","LU0061475181.USD","BK4588","BK4534","LU0130517989.USD","LU1941712264.USD","LU0320765489.SGD","LU0477156953.USD","LU0965509101.SGD","LU1066053197.SGD","LU1868837136.USD","LU1291159041.SGD","ABBV","SGXZ57979304.SGD","SG9999015358.SGD","LU0965508806.USD","ROG"],"gpt_icon":1},{"id":"1190397083","title":"美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1190397083","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190397083?lang=zh_cn&edition=full","pubTime":"2025-12-20 03:22","pubTimestamp":1766172127,"startTime":"0","endTime":"0","summary":"美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0477156953.USD","BK4578","IE00BJT1NW94.SGD","LU1066051811.HKD","LU1989771016.USD","LU1645745479.HKD","LU1032466523.USD","LU0861579265.USD","IE00B3T34201.USD","LU1291159041.SGD","LU0265550946.USD","LU0208291251.USD","LU0320765489.SGD","LU1061106388.HKD","LU0306806265.USD","LU1868836591.USD","IE00BSNM7G36.USD","IE0009355771.USD","LU1670756490.USD","BK4533","BK4532","LU0320765646.SGD","SG9999001176.SGD","SG9999015341.SGD","LU1261432733.SGD","SG9999015986.USD","LU1064927863.SGD","IE00B4R5TH58.HKD","LU2089984988.USD","LU0114720955.EUR","LU1037948541.HKD","AMGN","IE00B1BXHZ80.USD","LU1585245621.USD","LU0130102774.USD","LU1093756168.USD","LU1046248800.SGD","SG9999002232.USD","LU0971552830.HKD","IE000M9KFDE8.USD","BK4566","LU0096364046.USD","LU0965509283.SGD","LU0306807586.USD","LU1571399168.USD","LU0109394709.USD","LU2106854487.HKD","LU0321505868.SGD","LU1917777945.USD","SG9999015952.SGD","LU1069347547.HKD","LU1941712264.USD","LU0882574055.USD","LU1868837136.USD","LU1093756325.SGD","LU2125154935.USD","IE00BLSP4452.SGD","LU1941712348.USD","SG9999015978.USD","LU1400636657.SGD","LU0456855351.SGD","IE00BBT3K403.USD","LU0122379950.USD","LU2361045086.USD","LU1989772840.SGD","SG9999001440.SGD","LU2087621335.USD","IE00BWDBJ516.SGD","SG9999014542.SGD","IE00BFXG1179.USD","LU0161305163.EUR","LU1035777561.USD","LU2112291526.USD","LU0058720904.USD","BK4516","BIIB","LU1116320737.USD","LU1670711123.USD","LU1983299246.USD","LU1929549753.HKD","LU1839511570.USD","IE0002270589.USD","LU0070302665.USD","LU1868836757.USD","BK4599","LU2324357040.USD","LU1868837300.USD","LU0648001328.SGD","IE00B2B36J28.USD","LU1015430645.USD","LU1162221912.USD","LU1400636491.USD","LU0980610538.SGD","RHHBY","LU2242646821.SGD","04332","LU0265550359.USD","LU1974910355.USD","SG9999002224.SGD","LU1023059063.AUD","LU1934455194.USD","SG9999001176.USD","IE00B7SZLL34.SGD","LU0203347892.USD","LU0234570918.USD","LU1074936037.SGD","LU1228905540.USD","LU1302929846.USD","BK4581","LU0971552673.USD","BK4568","LU0965509101.SGD","IE00BFTCPJ56.SGD","LU2360032135.SGD","LU0211331839.USD","IE00BN8TJ469.HKD","LU0985481810.HKD","LU0266013472.USD","SG9999014575.USD","LU0289739699.SGD","BK5011","LU2023250843.SGD","LU1778281490.HKD","LU1098665638.USD","LU1201861249.SGD","LU0985320562.USD","LU1323610961.USD","LU2023250504.SGD","LU2361044865.SGD","BK4559","LU2461242641.AUD","LU1989772923.USD","LU1674673428.USD","IE00BQJZX424.USD","LU0109981661.USD","BK4550","LU2468319806.SGD","LU2361044949.HKD","LU0321505439.SGD","LU0238689110.USD","IE00BZ1G4Q59.USD","LU1670710588.SGD","BK4007","IE00BJJMRZ35.SGD","LU1057294990.SGD","LU1481600234.SGD","SG9999015358.SGD","LU0965508806.USD","LU0106261372.USD","LU1674673691.USD","LU0823416689.USD","NVS","GILD","IE00BLSP4239.USD","LU1066053197.SGD","SNY","LU0098860793.USD","LU0545562505.USD","LU1481599808.USD","LU1934455863.HKD","LU2125154778.USD","LU1699723380.USD","LU1202635105.USD","LU0575583348.USD","BK4588","LU0237698245.USD","LU1035773651.USD","LU1487256676.USD","LU0267386448.USD","SG9999014567.USD","LU0130517989.USD","LU1309081286.SGD","MRK","LU1116320901.HKD","LU0868494617.USD","BK4585","LU1228905037.USD","LU1670710661.SGD","LU1934455277.USD","LU2242652126.USD","LU0203345920.USD","BK4534","LU1400636574.HKD","LU1718418525.SGD","LU1066051225.USD","LU0965509010.AUD","GSK","BK4583","LU0225771236.USD","SG9999014559.SGD","BK4139","IE00BKVL7J92.USD","LU1430594728.SGD","IE0034235071.USD","LU0061475181.USD","LU0006306889.USD","LU2133065610.SGD","SG9999015945.SGD","BMY","LU1037948897.HKD","SG9999013999.USD","IE00B19Z3581.USD","LU0889565916.HKD","LU1670711040.USD","LU1066051498.USD","SGXZ57979304.SGD","IE00B19Z3B42.SGD","LU1868836914.USD","LU0234572021.USD","LU0320765992.SGD","IE0002141913.USD","LU0225284248.USD"],"gpt_icon":0},{"id":"1185501574","title":"公司将通过Trumprx网站以更低价格直接向消费者提供多种药物-美国官员","url":"https://stock-news.laohu8.com/highlight/detail?id=1185501574","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185501574?lang=zh_cn&edition=full","pubTime":"2025-12-20 03:21","pubTimestamp":1766172084,"startTime":"0","endTime":"0","summary":"公司将通过Trumprx网站以更低的价格向消费者直接提供多种药物-美国官员","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0061475181.USD","LU0234572021.USD","BK4583","LU1023059063.AUD","LU1032466523.USD","LU1162221912.USD","LU0306807586.USD","LU1868837136.USD","LU1098665638.USD","IE00BN8TJ469.HKD","LU0321505439.SGD","LU1057294990.SGD","SG9999015952.SGD","LU1989772840.SGD","LU2133065610.SGD","BMY","IE0002270589.USD","LU0477156953.USD","LU0971552673.USD","LU1046248800.SGD","LU1487256676.USD","LU0320765489.SGD","LU1868836591.USD","LU0203345920.USD","LU1670711040.USD","LU1989772923.USD","LU2089984988.USD","LU2361044949.HKD","IE00B3T34201.USD","LU0225771236.USD","IE00B19Z3581.USD","LU1061106388.HKD","LU1670710661.SGD","LU1302929846.USD","LU1571399168.USD","LU1718418525.SGD","IE00BBT3K403.USD","IE00BLSP4452.SGD","LU0456855351.SGD","BK4139","LU0267386448.USD","LU1093756168.USD","LU2324357040.USD","IE00BWDBJ516.SGD","MRK","LU0289739699.SGD","LU1066051498.USD","LU1983299246.USD","LU0971552830.HKD","LU1585245621.USD","IE00BFXG1179.USD","SG9999015358.SGD","LU0306806265.USD","LU2112291526.USD","LU0130102774.USD","LU2461242641.AUD","SG9999002232.USD","LU2087621335.USD","LU1645745479.HKD","BK4550","IE00B2B36J28.USD","LU1778281490.HKD","LU0161305163.EUR","LU2242646821.SGD","LU0225284248.USD","LU1670711123.USD","LU2125154935.USD","IE00BQJZX424.USD","LU0130517989.USD","LU2361044865.SGD","LU0980610538.SGD","LU0208291251.USD","LU0321505868.SGD","LU2242652126.USD","IE0034235071.USD","LU2023250843.SGD","LU0575583348.USD","LU0545562505.USD","LU1400636574.HKD","IE00BFTCPJ56.SGD","LU1868836757.USD","SG9999015341.SGD","LU2125154778.USD","LU0266013472.USD","LU1674673428.USD","LU0096364046.USD","LU1941712264.USD","LU0237698245.USD","SG9999002224.SGD","LU1941712348.USD","LU0882574055.USD","LU0098860793.USD","LU1674673691.USD","LU1400636657.SGD","SGXZ57979304.SGD","BK4559","IE00B7SZLL34.SGD","LU0320765992.SGD","LU0006306889.USD","LU1400636491.USD","IE00B4R5TH58.HKD","SG9999001440.SGD","LU0648001328.SGD","IE00BLSP4239.USD","LU0320765646.SGD","LU1917777945.USD","LU0265550946.USD","LU2106854487.HKD","LU0109981661.USD","LU1093756325.SGD","IE00BSNM7G36.USD","LU1066053197.SGD","LU0122379950.USD","GILD","LU2023250504.SGD","IE00B1BXHZ80.USD","LU0889565916.HKD","LU0868494617.USD","SG9999001176.USD","LU1989771016.USD","LU2361045086.USD","BK4578","LU2468319806.SGD","AMGN","LU1074936037.SGD","LU1868836914.USD","LU1066051225.USD","BK4533","BK5011","LU0965509101.SGD","LU1064927863.SGD","LU2360032135.SGD","SG9999013999.USD","BK4516","LU0211331839.USD","LU1934455863.HKD","IE000M9KFDE8.USD","LU1069347547.HKD","BK4581","LU1430594728.SGD","LU1037948541.HKD","LU0265550359.USD","SG9999014567.USD","IE00BJJMRZ35.SGD","LU0238689110.USD","LU1015430645.USD","LU1228905037.USD","LU1323610961.USD","LU1929549753.HKD","SG9999015945.SGD","SG9999015986.USD","LU0234570918.USD","LU0985481810.HKD","LU1291159041.SGD","LU1934455194.USD","SG9999014575.USD","LU1037948897.HKD","BK4588","IE00B19Z3B42.SGD","LU0965508806.USD","IE00BJT1NW94.SGD","LU0965509010.AUD","GSK","SG9999001176.SGD","LU1116320901.HKD","IE00BZ1G4Q59.USD","LU1066051811.HKD","LU0114720955.EUR","BK4585","BK4007","LU0861579265.USD","LU1481599808.USD","LU1670756490.USD","LU1202635105.USD","IE0002141913.USD","BK4599","LU1868837300.USD","LU0823416689.USD","LU0058720904.USD","LU1035773651.USD","04332","SG9999015978.USD","LU1309081286.SGD","BK4534","LU1228905540.USD","LU0965509283.SGD","LU1839511570.USD","LU0109394709.USD","LU1481600234.SGD","LU0203347892.USD","LU1934455277.USD","LU1035777561.USD","LU1699723380.USD","BK4532","IE00BKVL7J92.USD","SG9999014542.SGD","LU0106261372.USD","LU0985320562.USD","LU1974910355.USD","LU1670710588.SGD","BK4568","LU1116320737.USD","IE0009355771.USD","TRUMP","SG9999014559.SGD","LU1261432733.SGD","BK4566","LU1201861249.SGD","LU0070302665.USD"],"gpt_icon":0},{"id":"2591674889","title":"葛兰素史克哮喘药物Exdensur获英国批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2591674889","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591674889?lang=zh_cn&edition=full","pubTime":"2025-12-16 10:42","pubTimestamp":1765852948,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["GSK.UK","LU1829250122.USD","BK4588","BK4585","GSK","BK4532","BK4007"],"gpt_icon":0},{"id":"2582936115","title":"AN2治疗公司与GSK达成合作，共同推进基于硼的结核病治疗方法的发展AN2 Therapeutics Enters into Collaboration with GSK to Advance Boronased Therapies for Tuberculosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2582936115","media":"动脉网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582936115?lang=zh_cn&edition=full","pubTime":"2025-11-11 14:19","pubTimestamp":1762841940,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics has entered into a research collaboration with GSK to develop new treatments for tuberculosis .AN2 Therapeutics与GSK达成了一项研究合作，以开发治疗结核病的新疗法。经验证的LeuRS靶点是多种化合物的基础，包括用于治疗NTM肺病的在研药物epetraborole、用于治疗结核病的在研药物ganfeborole，以及获得FDA批准的抗真菌药物tavaborole。This collaboration builds on previous work between AN2’s team and GSK’s Global Health research and development group. It represents a joint effort to explore innovative approaches that could help address the growing burden of TB, particularly in low-income countries.这项合作建立在AN2团队与GSK全球健康研发小组之前的工作基础之上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111114212194fcffac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111114212194fcffac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","GSK.UK","GSK","ANTX","BK4585","LENZ","BK4007","BK4139","BK4539","LU1829250122.USD","BK4588"],"gpt_icon":0},{"id":"2582608828","title":"探索“功能性治愈”新路径，展望“无乙肝的未来”","url":"https://stock-news.laohu8.com/highlight/detail?id=2582608828","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582608828?lang=zh_cn&edition=full","pubTime":"2025-11-10 15:45","pubTimestamp":1762760739,"startTime":"0","endTime":"0","summary":"在第八届中国国际进口博览会上，葛兰素史克（GSK）举办了以“为了没有乙肝的未来”为主题的医学专场活动，聚焦慢性乙型肝炎（CHB）防治与“功能性治愈”的前沿突破，探讨乙肝防治的最新科研进展与未来诊疗格局的变革。从控制到治愈：乙肝防治进入“存量管理”新阶段我国乙肝防治历经三十余年努力，疫苗接种构筑起坚实防线，使新发感染率显著下降。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://biz.eastmoney.com/a/202511103559749093.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4561","GSK","LU1829250122.USD","BK4532","BK4007","BK4200","BK4585","ASO","GSK.UK","BK4588","CHB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gsk.com","stockEarnings":[{"period":"1week","weight":-0.0431},{"period":"1month","weight":-0.0101},{"period":"3month","weight":0.0982},{"period":"6month","weight":0.328},{"period":"1year","weight":0.442},{"period":"ytd","weight":-0.0167}],"compareEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":0.0302},{"period":"3month","weight":0.041},{"period":"6month","weight":0.1021},{"period":"1year","weight":0.1691},{"period":"ytd","weight":0.0143}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"GSK Plc于1999年12月6日在英国成立的公众服务有限公司，是一个世界领先的研究型制药和保健公司，由 Glaxo Wellcome plc和SmithKline Beecham plc合并而成。公司致力于开发较现有治疗方案明显改善的新产品，为病人和政府、保险公司或其他第三方提供帮助。","yearOnYearQuotes":[{"month":1,"riseRate":0.565217,"avgChangeRate":0.012311},{"month":2,"riseRate":0.466667,"avgChangeRate":-0.001972},{"month":3,"riseRate":0.622222,"avgChangeRate":0.021018},{"month":4,"riseRate":0.673913,"avgChangeRate":0.032633},{"month":5,"riseRate":0.413043,"avgChangeRate":-0.008096},{"month":6,"riseRate":0.586957,"avgChangeRate":0.009648},{"month":7,"riseRate":0.543478,"avgChangeRate":0.003945},{"month":8,"riseRate":0.586957,"avgChangeRate":0.005806},{"month":9,"riseRate":0.521739,"avgChangeRate":0.005973},{"month":10,"riseRate":0.521739,"avgChangeRate":0.013062},{"month":11,"riseRate":0.478261,"avgChangeRate":0.009917},{"month":12,"riseRate":0.608696,"avgChangeRate":0.014188}],"exchange":"NYSE","name":"葛兰素史克","nameEN":"GlaxoSmithKline PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"葛兰素史克(GSK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供葛兰素史克(GSK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"葛兰素史克,GSK,葛兰素史克股票,葛兰素史克股票老虎,葛兰素史克股票老虎国际,葛兰素史克行情,葛兰素史克股票行情,葛兰素史克股价,葛兰素史克股市,葛兰素史克股票价格,葛兰素史克股票交易,葛兰素史克股票购买,葛兰素史克股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"葛兰素史克(GSK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供葛兰素史克(GSK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}